Of the remaining 21 tumours, three harboured biallelic somatic NF1 alterations; two had homozygous NF1 copy number loss (detected by visual inspection of read counts using the Integrative Genomics Viewer); three had non‐synonymous NF1 mutations; and two had a heterozygous loss of NF1. The gene discussed is NF1; the disease is neoplasm.